TCBWMS
CUE icon

Texas Capital Bank Wealth Management Services’s Cue Biopharma CUE Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722K Buy
22,881
+9,634
+73% +$218K 0.04% 174
2026
Q1 		$91.4K Sell
13,247
-1,442
-10% -$13.5K 0.01% 338
2025
Q4 		$135K Buy
14,689
+13,586
+1,232% +$250K 0.01% 327
2025
Q3 		$23.8K Hold
1,103
– – ﹤0.01% 254
2025
Q2 		$22.6K Hold
1,103
– – ﹤0.01% 222
2025
Q1 		$30.2K Hold
1,103
– – ﹤0.01% 207
2024
Q4 		$36.1K Buy
+1,103
New +$41.5K ﹤0.01% 160

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Texas Capital Bank Wealth Management Services's CUE Position: Q2 2026 in Review

Texas Capital Bank Wealth Management Services increased its Cue Biopharma (CUE) stake by 73% in Q2 2026, buying an estimated $218K and bringing the position to 22,881 shares worth $722K. The position accounts for 0.04% of the portfolio, ranked #174.

Texas Capital Bank Wealth Management Services first reported a position in CUE in Q4 2024 and has held it in 7 quarters since. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Texas Capital Bank Wealth Management Services held 22,881 shares of Cue Biopharma worth $722K as of Q2 2026.
  • Texas Capital Bank Wealth Management Services bought 9,634 Cue Biopharma shares in Q2 2026, an estimated $218K.
  • Cue Biopharma made up 0.04% of Texas Capital Bank Wealth Management Services's portfolio in Q2 2026, its #174 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Cue Biopharma in Q4 2024 and has held it in 7 quarters since.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q2 2026, filed 7 Aug 2026.